Genlantis
Genlantis, a San Diego life sciences firm founded in 1998, designs and supplies biological reagents and specialty products spanning transfection, cell culture, RNAi, competent cells, expression systems, and proteomics for academic and biotech research laboratories; since 2023 it has operated as a product line under AMSBIO distribution.
- Company typePrivate
- Founded1998
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Genlantis firmographics
Firmographics- Name
- Genlantis
- Legal name
- Genlantis Inc.
- Website
- https://genlantis.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- Genlantis, a San Diego life sciences firm founded in 1998, designs and supplies biological reagents and specialty products spanning transfection, cell culture, RNAi, competent cells, expression systems, and proteomics for academic and biotech research laboratories; since 2023 it has operated as a product line under AMSBIO distribution.
- Ownership category
- akta.pro rank
Where Genlantis is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Genlantis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Research Reagents & Media Sales: Sale of transfection reagents, cell culture media, RNAi products, competent cells, and proteomics reagents to research laboratories and biotechnology companies. Products are sold as catalog items through distribution channels including AMSBIO following acquisition.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog research reagents |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Genlantis product offering
Product offeringCore offering
Genlantis designs and develops biological reagents and specialty life science systems, supplying molecular biology products including transfection reagents (DNA, siRNA, neuronal, protein, insect), cell culture media and reagents, species-specific cell lines, RNAi siRNA generation kits, competent cells, protein expression systems, and proteomics tools. The company sells its product catalog to research laboratories and biotechnology firms, with distribution now handled by parent company AMSBIO following a 2023 acquisition.
Differentiator
Problem solved
Functional benefit
Products and services
- Transfection Reagents
Companies that use Genlantis
Customer profileSegments3 records
Ideal customer profiles3 records
Genlantis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Genlantis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AMSBIOcoreAMSBIO acquired Genlantis and now distributes the complete Genlantis product line including transfection reagents, cell culture media, RNAi products, and proteomics reagents. The acquisition enables continued customer access to Genlantis products through AMSBIO's established distribution channels.
Scale indicators1 record
Genlantis competitors and assessment
Company assessmentBroad incumbents
- Lonza Bioscience: Major supplier of cell culture media and bioprocessing reagents, competing with Genlantis in the Cells & Media category particularly for biopharma customers.
- Bio-Rad Laboratories: Supplies molecular biology reagents, competent cells, and protein analysis tools that compete with Genlantis's COMP CELLS/EXPRESSION and Proteomics lines.
- Corning Life Sciences: Provides cell culture media and consumables used in research and bioprocessing workflows, directly comparable to Genlantis's Cell Culture Media offerings.
- Thermo Fisher Scientific (Life Sciences): Dominant broad-line supplier of transfection reagents (Lipofectamine), cell culture media, and RNAi tools through its Life Sciences/Invitrogen portfolio — competes across every Genlantis category.
- MilliporeSigma (Life Science): Sells transfection reagents (CalPhos), cell culture media, and a comprehensive catalog of molecular biology reagents overlapping with Genlantis's full product line.
Others
- AMSBIO: Acquired Genlantis in 2023 and now distributes the product line; AMSBIO itself supplies a broad catalog of life science reagents and cell culture products that includes Genlantis as a brand, making it both parent and channel-adjacent peer.
Direct peers
- Polysciences: Producer of transfection reagents and specialty biomaterials for molecular and cell biology research, comparable in product mix and customer base to Genlantis.
- Takara Bio: Provides molecular biology reagents including competent cells, RNAi tools, and cell culture products, overlapping heavily with Genlantis's competent cells, RNAi, and protein expression lines.
- STEMCELL Technologies: Supplies cell culture media, reagents, and stem cell products to academic and biopharma researchers — directly comparable to Genlantis's Cells & Media and stem cell offerings.
- Mirus Bio: Specialist manufacturer of transfection reagents (DNA, siRNA, mRNA, protein delivery) for research and bioprocessing, directly overlapping Genlantis's core transfection product line.
Market position
Customer concentration
Genlantis social profiles
Digital presenceGenlantis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genlantis leadership team
Management profileNumber of profiles
Genlantis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genlantis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genlantis
What does Genlantis do?
Genlantis designs and develops biological reagents and specialty life science systems, supplying molecular biology products including transfection reagents (DNA, siRNA, neuronal, protein, insect), cell culture media and reagents, species-specific cell lines, RNAi siRNA generation kits, competent cells, protein expression systems, and proteomics tools. The company sells its product catalog to research laboratories and biotechnology firms, with distribution now handled by parent company AMSBIO following a 2023 acquisition.
Is Genlantis a public or private company?
Genlantis is a private company. It is classified as corporate owned and is currently acquired.
When was Genlantis founded?
Genlantis was founded in 1998. It employs 1 to 10 people.
Where is Genlantis based?
Genlantis is headquartered in San Diego, United States, in the North America region.
How does Genlantis make money?
One revenue line is on record: research Reagents & Media Sales.
Who are Genlantis's main competitors?
Broad incumbents on record are Lonza Bioscience, Bio-Rad Laboratories, Corning Life Sciences, Thermo Fisher Scientific (Life Sciences) and MilliporeSigma (Life Science). AMSBIO is listed as an others. Direct peers are Polysciences, Takara Bio, STEMCELL Technologies and Mirus Bio.
Does Genlantis have an API?
No public API is recorded for Genlantis.